Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial

Autor: Huober, J., Fasching, P.A., Barsoum, M., Petruzelka, L., Wallwiener, D., Thomssen, C., Reimer, T., Paepke, S., Azim, H.A., Ragosch, V., Kubista, E., Baumgärtner, A.K., Beckmann, M.W., May, C., Nimmrich, I., Harbeck, N.
Zdroj: In The Breast February 2012 21(1):27-33
Databáze: ScienceDirect